These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 114976

  • 1. [Pharmacokinetic perturbations in kidney failure. Anomalies of metabolites and tissue diffusion (author's transl)].
    Fabre J, Balant L, Rudhardt M, Blanchard P.
    Nouv Presse Med; ; 8(33):2677-82. PubMed ID: 114976
    [Abstract] [Full Text] [Related]

  • 2. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
    Prendergast BD.
    Clin Pharm; 1984; 3(5):473-85. PubMed ID: 6435940
    [Abstract] [Full Text] [Related]

  • 3. Aminoglycoside renal cortical kinetics: a clue to mechanisms of nephrotoxicity.
    Whelton A.
    Prog Clin Biol Res; 1979; 35():33-41. PubMed ID: 395539
    [Abstract] [Full Text] [Related]

  • 4. [Aminoglycoside nephrotoxicity. I. Clinical aspects, morphology and tissue pharmacokinetics].
    Fabre J.
    Nephrologie; 1980; 1(1):37-43. PubMed ID: 7029331
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Nephrotoxicity of aminoglycosides. Effects on pharmacokinetics and prevention.
    Brogard JM, Comte F, Spach MO.
    Contrib Nephrol; 1984; 42():182-95. PubMed ID: 6398194
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Aminoglycoside nephrotoxicity--a tale of two transports.
    Whelton A, Solez K.
    J Lab Clin Med; 1982 Feb; 99(2):148-55. PubMed ID: 7038007
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Possibilities of the preclinical assessment of changes in pharmacokinetics as a result of renal failure].
    Schück O, Morávek J, Hatala M.
    Cas Lek Cesk; 1983 Jul 22; 122(29):897-900. PubMed ID: 6616551
    [No Abstract] [Full Text] [Related]

  • 14. [Prediction of aminoglycoside nephrotoxicity].
    Lucht F, Peyramond D, Robert D, Vincent P.
    Sem Hop; 1982 Sep 30; 58(35):2021-5. PubMed ID: 6293091
    [Abstract] [Full Text] [Related]

  • 15. Renal parenchymal accumulation of aminoglycoside antibiotics in rats.
    Luft FC, Kleit SA.
    J Infect Dis; 1974 Dec 30; 130(6):656-9. PubMed ID: 4427081
    [No Abstract] [Full Text] [Related]

  • 16. The intrarenal distribution of aztreonam in healthy and diseased kidneys: clinical therapeutic implications.
    Watson AJ, Stout RL, Whelton A.
    J Infect Dis; 1984 Nov 30; 150(5):631-5. PubMed ID: 6541673
    [Abstract] [Full Text] [Related]

  • 17. [Netilmicin and tobramycin: comparative evaluation of pharmacokinetics, nephrotoxicity, and therapeutic efficacy in animal studies (author's transl)].
    Marre R, Abraham M, Freiesleben H, Sack K.
    Arzneimittelforschung; 1979 Nov 30; 29(6):940-5. PubMed ID: 582788
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.